Effect of Sancao Lichang Decoction in the treatment of diarrhea irritable bowel syndrome based on TLR4/MyD88/NF-?B signaling pathway
Phase 1
Recruiting
- Conditions
- Irritable bowel syndrome
- Registration Number
- ITMCTR2100004976
- Lead Sponsor
- Xuzhou Central Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. It complies with the diagnostic criteria of Western medicine and the diagnosis criteria of TCM syndrome;
2, Age between 18 and 60, gender is not limited;
3. Have normal communication skills and sign informed consent.
Exclusion Criteria
Diarrhea caused by other organic diseases; The syndrome of traditional Chinese medicine is spleen-kidney Yang deficiency and cold drink stops; Patients with severe cardiovascular and cerebrovascular diseases, respiratory diseases and other diseases and unstable conditions; Organic lesions of the digestive tract, or systemic diseases affecting digestive tract motility; Pregnant and lactating women; Other uncontrolled conditions affect the treatment of the trial.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TNF-a, IL-6;TCM symptom score;TLR4/MyD88/NF-?B signaling pathway indicators;
- Secondary Outcome Measures
Name Time Method